Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Dechra Pharmaceuticals PLC Major Shareholding Notification 2013

Jan 11, 2013

4797_mrq_2013-01-11_46f947c2-e312-42f2-81f8-97bb3b097501.html

Major Shareholding Notification

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3965V

Dechra Pharmaceuticals PLC

11 January 2013

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying issuer

of existing shares to which voting rights are

attached: ii
Dechra Pharmaceuticals plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights x
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the

notification obligation: iii
Invesco Limited
4. Full name of shareholder(s) (if different from 3.):iv
5. Date of the transaction and date on

which the threshold is crossed or

reached: v
09 January 2013
6. Date on which issuer notified: 11 January 2013
7. Threshold(s) that is/are crossed or

reached: vi, vii
4%, 5%
8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of

shares



if possible using

the ISIN CODE
Situation previous

to the triggering

transaction
Resulting situation after the triggering transaction
Number

of

Shares
Number

of

Voting

Rights
Number

of shares
Number of voting

rights
% of  voting rights x
Direct Direct xi Indirect xii Direct Indirect
Ordinary 1p Shares 4,352,940 4,352,940 4,348,519 5.00%
GB0009633180
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial

instrument
Expiration

date xiii
Exercise/

Conversion Period xiv
Number of voting

rights that may be

acquired if the

instrument is

exercised/ converted.
% of voting

rights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial

instrument
Exercise price Expiration date xvii Exercise/

Conversion period xviii
Number of voting rights instrument refers to % of voting rights xix, xx
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
4,348,519 5.00%
9. Chain of controlled undertakings through which the voting rights and/or the

financial instruments are effectively held, if applicable: xxi
Invesco Asset Management Ltd - 939,162

Invesco Fund Managers Ltd - 3,068,384

Invesco Asset Management Dublin Ltd - 274,501

Invesco Asset Management Ltd & Invesco Advisers Inc. - 23,461

Invesco Canada Ltd & Invesco Advisers Inc. - 21,954

Invesco GT Management S.A - 16,190

Invesco Asset Management Japan Ltd - 6,145

Invesco PowerShares Capital Management Limited - 4,610
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease

to hold:
12. Date on which proxy holder will cease to hold

voting rights:
13. Additional information:
14. Contact name: Sam Edwards
15. Contact telephone number: 01491 416381
Note: Annex should only be submitted to the FSA not the issuer
Annex: Notification of major interests in share
A: Identity of the persons or legal entity subject to the notification obligation
Full name

(including legal form of legal entities)
Contact address

(registered office for legal entities)
Phone number & email
Other useful information

(at least legal representative for legal persons)
B: Identity of the notifier, if applicable
Full name Invesco Limited
Contact address Registered address:

30 Finsbury Square, London. EC2A 1AG
Phone number & email 020 7638 0731
Other useful information

(e.g. functional relationship with the person or legal entity subject to the notification obligation)
C: Additional information
For notes on how to complete form TR-1 please see the FSA website.

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLDMGMMDMFGFZM